Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolus (EOLS) Total Current Liabilities (2018 - 2025)

Historic Total Current Liabilities for Evolus (EOLS) over the last 8 years, with Q3 2025 value amounting to $66.7 million.

  • Evolus' Total Current Liabilities rose 969.5% to $66.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $66.7 million, marking a year-over-year increase of 969.5%. This contributed to the annual value of $63.0 million for FY2024, which is 3037.63% up from last year.
  • According to the latest figures from Q3 2025, Evolus' Total Current Liabilities is $66.7 million, which was up 969.5% from $63.8 million recorded in Q2 2025.
  • Evolus' Total Current Liabilities' 5-year high stood at $87.6 million during Q1 2021, with a 5-year trough of $40.7 million in Q1 2023.
  • Its 5-year average for Total Current Liabilities is $57.1 million, with a median of $54.1 million in 2024.
  • Examining YoY changes over the last 5 years, Evolus' Total Current Liabilities showed a top increase of 46104.34% in 2021 and a maximum decrease of 6800.91% in 2021.
  • Evolus' Total Current Liabilities (Quarter) stood at $57.7 million in 2021, then decreased by 19.34% to $46.5 million in 2022, then grew by 3.83% to $48.3 million in 2023, then skyrocketed by 30.38% to $63.0 million in 2024, then rose by 5.96% to $66.7 million in 2025.
  • Its last three reported values are $66.7 million in Q3 2025, $63.8 million for Q2 2025, and $56.2 million during Q1 2025.